Bone-marrow-derived side population cells for myocardial regeneration

Area of Science:

• Regenerative Medicine
• Cardiovascular Biology
• Stem Cell Biology

Background:

• Bone marrow-derived stem cells show promise for myocardial regeneration.
• Bone marrow mononuclear cells (MNCs) are heterogeneous, containing stem cell populations.
• Side population (SP) cells possess high differentiation capacity.

Purpose of the Study:

• To investigate the role of murine and human bone marrow-derived SP cells in myocardial regeneration.
• To assess the potential of SP cells to differentiate into cardiomyocytes.
• To compare the efficacy of SP cells versus unfractionated MNCs in improving cardiac function post-injury.

Main Methods:

• In vitro culture of mouse bone marrow SP cells with neonatal cardiomyocytes.
• In vivo delivery of fluorescently labeled mouse bone marrow SP cells into injured myocardium.
• Assessment of differentiation markers (alpha-actinin, cardiac troponin I) via immunohistochemistry and gene expression.
• Transcriptome analysis of bone marrow cells.
• Injection of human bone marrow MNCs and SP cells into cryoinjured rat hearts.
• Evaluation of cardiac function using echocardiography.

Main Results:

• Mouse bone marrow SP cells expressed cardiac-specific proteins and genes post-differentiation and engraftment.
• Human bone marrow MNCs and SP cells were identified in rat myocardium one month post-injection.
• Human SP cells expressed cardiac troponin I and cardiac transcripts.
• Both human MNCs and SP cells improved cardiac systolic function after cryoinjury.
• Human SP cells enhanced cardiac function earlier and more effectively than MNCs, despite lower cell numbers.

Conclusions:

• Murine and human bone marrow-derived SP cells can adopt a cardiac fate.
• Human bone marrow-derived SP cells are superior to unfractionated MNCs in promoting left ventricular systolic function recovery after myocardial cryoinjury.